• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新型吡唑并[3,4-d]嘧啶衍生物的设计、合成与抗肿瘤评价

Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives.

作者信息

Kandeel Manal M, Mohamed Lamia W, Abd El Hamid Mohammed K, Negmeldin Ahmed T

机构信息

Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

出版信息

Sci Pharm. 2012 Jul-Sep;80(3):531-45. doi: 10.3797/scipharm.1204-23. Epub 2012 Jun 25.

DOI:10.3797/scipharm.1204-23
PMID:23008804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3447607/
Abstract

A new series of pyrazolo[3,4-d]pyrimidines has been synthesized. The new compounds were tested for their antitumor activity on 60 different cell lines, and some of the compounds were found to have potent antitumor activity. In particular, 2-hydroxybenzaldehyde [1-(4-chlorophenyl)-3-methyl-1H-pyrazolo-[3,4-d]pyrimidin-4-yl]hydrazone (VIIa) was found to be the most effective among the other derivatives, showing IC50 values of 0.326 to 4.31 μM on 57 different cell lines.

摘要

已合成了一系列新的吡唑并[3,4 - d]嘧啶。对这些新化合物在60种不同细胞系上进行了抗肿瘤活性测试，发现其中一些化合物具有强效抗肿瘤活性。特别是，发现2 - 羟基苯甲醛[1 - (4 - 氯苯基)-3 - 甲基 - 1H - 吡唑并[3,4 - d]嘧啶 - 4 - 基]腙（VIIa）在其他衍生物中最为有效，在57种不同细胞系上显示出0.326至4.31μM的IC50值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/95c5ef1c17d6/scipharm-2012-80-531f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/b720cf182314/scipharm-2012-80-531f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/4fac84c8094c/scipharm-2012-80-531f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/f0921a7ede40/scipharm-2012-80-531f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/8546c26f8136/scipharm-2012-80-531f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/95c5ef1c17d6/scipharm-2012-80-531f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/b720cf182314/scipharm-2012-80-531f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/4fac84c8094c/scipharm-2012-80-531f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/f0921a7ede40/scipharm-2012-80-531f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/8546c26f8136/scipharm-2012-80-531f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0a9/3447607/95c5ef1c17d6/scipharm-2012-80-531f5.jpg

相似文献

1
Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives.新型吡唑并[3,4-d]嘧啶衍生物的设计、合成与抗肿瘤评价
Sci Pharm. 2012 Jul-Sep;80(3):531-45. doi: 10.3797/scipharm.1204-23. Epub 2012 Jun 25.
2
Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.合成及含有苯并噻唑环系的一些新型吡唑并嘧啶的生物评价。
Acta Pharm. 2013 Mar;63(1):19-30. doi: 10.2478/acph-2013-0001.
3
Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.新型吡唑并[3,4-d]嘧啶类化合物作为潜在的细胞毒剂：设计、合成、分子对接和 CDK2 抑制。
Anticancer Agents Med Chem. 2019;19(11):1368-1381. doi: 10.2174/1871520619666190417153350.
4
Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.一些新型吡唑并[1,5-a]嘧啶和吡唑并[5,1-c][1,2,4]三嗪的合成、表征、抗菌活性和抗癌活性。
Med Chem. 2020;16(6):750-760. doi: 10.2174/1573406415666190620144404.
5
Synthesis and evaluation of antitumor activity of new 4-substituted thieno[3,2-d]pyrimidine and thienotriazolopyrimidine derivatives.新型4-取代噻吩并[3,2-d]嘧啶和噻吩并三唑并嘧啶衍生物的合成及其抗肿瘤活性评价
Acta Pharm. 2017 Dec 20;67(4):527-542. doi: 10.1515/acph-2017-0039.
6
Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.新型3,6-二甲基-1-苯基-4-(取代甲氧基)吡唑并[3,4-d]嘧啶衍生物的合成、表皮生长因子受体抑制作用及抗癌活性
Anticancer Agents Med Chem. 2017;17(10):1389-1400. doi: 10.2174/1872211311666170213105004.
7
Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents.新型吡唑并嘧啶衍生物作为抗癌和抗5-脂氧合酶药物的合成及生物学评价
Bioorg Chem. 2016 Jun;66:160-8. doi: 10.1016/j.bioorg.2016.05.001. Epub 2016 May 7.
8
Anhydrous versus hydrated N4-substituted 1H-pyrazolo[3,4-d]pyrimidine-4,6-diamines: hydrogen bonding in two and three dimensions.无水与水合的N4-取代的1H-吡唑并[3,4-d]嘧啶-4,6-二胺：二维和三维中的氢键作用
Acta Crystallogr B. 2008 Oct;64(Pt 5):610-22. doi: 10.1107/S0108768108019903. Epub 2008 Sep 15.
9
Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties.一些含氨基酸部分的新型吡唑并[3,4-d]嘧啶的合成、抗癌及辐射防护活性
Arzneimittelforschung. 2009;59(2):96-103. doi: 10.1055/s-0031-1296370.
10
Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFR and EGFR inhibitors and apoptosis inducers.设计、合成及抗癌评估 1H-吡唑并[3,4-d]嘧啶衍生物作为有效 EGFR 和 EGFR 抑制剂及凋亡诱导剂。
Bioorg Chem. 2018 Oct;80:375-395. doi: 10.1016/j.bioorg.2018.06.017. Epub 2018 Jun 12.

引用本文的文献

1
Crystal structure determination and analyses of Hirshfeld surface, crystal voids, inter-molecular inter-action energies and energy frameworks of 1-benzyl-4-(methyl-sulfan-yl)-3a,7a-di-hydro-1-pyrazolo-[3,4-]pyrimidine.1-苄基-4-(甲硫基)-3a,7a-二氢-1-吡唑并[3,4-c]嘧啶的晶体结构测定以及 Hirshfeld 表面、晶体空隙、分子间相互作用能和能量框架分析
Acta Crystallogr E Crystallogr Commun. 2024 Jun 25;80(Pt 7):783-788. doi: 10.1107/S2056989024005954. eCollection 2024 Jun 1.
2
Design, synthesis, and biological evaluation with molecular dynamics study of novel pyrazolo[3,4-]pyrimidine derivatives as anti-cancer agents.新型吡唑并[3,4 -]嘧啶衍生物作为抗癌剂的设计、合成及分子动力学研究的生物学评价
RSC Adv. 2023 Jun 7;13(25):17074-17096. doi: 10.1039/d3ra00446e. eCollection 2023 Jun 5.
3

本文引用的文献

1
Synthesis and biological evaluation of some novel fused pyrazolopyrimidines as potential anticancer and antimicrobial agents.合成及一些新型稠合吡唑并嘧啶类化合物的生物评价作为潜在的抗癌和抗菌剂。
Arch Pharm (Weinheim). 2011 Mar;344(3):184-96. doi: 10.1002/ardp.201000188. Epub 2010 Dec 22.
2
A facile one-pot synthesis of 1-arylpyrazolo[3,4-d]pyrimidin-4-ones.一种简便的一锅法合成 1-芳基吡唑并[3,4-d]嘧啶-4-酮的方法。
Molecules. 2010 Apr 27;15(5):3079-86. doi: 10.3390/molecules15053079.
3
Pyrazolopyrimidines as highly potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 1-substituent.
Crystal structure determination, Hirshfeld surface, crystal void, inter-molecular inter-action energy analyses, as well as DFT and energy framework calculations of 2-(4-oxo-4,5-di-hydro-1-pyra-zolo[3,4-]pyrimidin-1-yl)acetic acid.2-(4-氧代-4,5-二氢-1-吡唑并[3,4-d]嘧啶-1-基)乙酸的晶体结构测定、 Hirshfeld表面、晶体空隙、分子间相互作用能分析以及密度泛函理论（DFT）和能量框架计算
Acta Crystallogr E Crystallogr Commun. 2022 Aug 31;78(Pt 9):953-960. doi: 10.1107/S2056989022008489. eCollection 2022 Sep 1.
4
CuAAC-ensembled 1,2,3-triazole-linked isosteres as pharmacophores in drug discovery: review.作为药物发现中药效基团的铜催化叠氮-炔环加成反应（CuAAC）组装的1,2,3-三唑连接的电子等排体：综述
RSC Adv. 2020 Feb 4;10(10):5610-5635. doi: 10.1039/c9ra09510a.
5
Substituted Pyrazoles and Their Heteroannulated Analogs-Recent Syntheses and Biological Activities.取代吡唑及其杂环同系物的最新合成及生物活性研究进展。
Molecules. 2021 Aug 18;26(16):4995. doi: 10.3390/molecules26164995.
6
Synthesis and anticancer activity of some new pyrazolo[3,4-d]pyrimidin-4-one derivatives.一些新型吡唑并[3,4-d]嘧啶-4-酮衍生物的合成及其抗癌活性
Molecules. 2014 Mar 18;19(3):3297-309. doi: 10.3390/molecules19033297.
吡唑并嘧啶作为高度有效的、选择性的哺乳动物雷帕霉素靶蛋白(mTOR)的 ATP 竞争性抑制剂：1 位取代基的优化。
Bioorg Med Chem Lett. 2010 Feb 15;20(4):1440-4. doi: 10.1016/j.bmcl.2009.12.086. Epub 2010 Jan 4.
4
Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity.合成一些具有潜在抗癌和辐射防护活性的新型吡唑并[3,4-d]嘧啶衍生物。
Eur J Med Chem. 2010 Jan;45(1):171-8. doi: 10.1016/j.ejmech.2009.09.039. Epub 2009 Sep 30.
5
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines.4-氨基取代的1H-吡唑并[3,4-d]嘧啶的合成、生物学评价及对接研究
Eur J Med Chem. 2008 Dec;43(12):2665-76. doi: 10.1016/j.ejmech.2008.01.034. Epub 2008 Feb 6.
6
Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides.取代的1-芳基-5-(1H-吡咯-1-基)-1H-吡唑-3-甲酰胺的合成、大麻素受体亲和力及分子模拟研究
J Med Chem. 2008 Mar 27;51(6):1560-76. doi: 10.1021/jm070566z. Epub 2008 Feb 23.
7
Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors.作为高效黄嘌呤氧化酶抑制剂的N-芳基-5-氨基-4-氰基吡唑衍生物的合成
Eur J Med Chem. 2008 Apr;43(4):771-80. doi: 10.1016/j.ejmech.2007.06.002. Epub 2007 Jul 5.
8
Pyrazolo[3,4-d]pyrimidines as potent inhibitors of the insulin-like growth factor receptor (IGF-IR).吡唑并[3,4-d]嘧啶作为胰岛素样生长因子受体（IGF-IR）的强效抑制剂。
Bioorg Med Chem Lett. 2007 Oct 1;17(19):5406-9. doi: 10.1016/j.bmcl.2007.07.037. Epub 2007 Jul 25.
9
3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.作为糖原合酶激酶-3β抑制剂的吡唑并嘧啶衍生物的3D-QSAR和分子对接研究
J Mol Graph Model. 2007 Mar;25(6):885-95. doi: 10.1016/j.jmgm.2006.08.009. Epub 2006 Sep 3.
10
Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3.新型糖原合成酶激酶-3杂环抑制剂的合成与评价
Bioorg Med Chem Lett. 2006 Apr 15;16(8):2091-4. doi: 10.1016/j.bmcl.2006.01.057. Epub 2006 Feb 7.